Epidermal growth factor receptor (EGFR) mutation is one of the most common genetic disorders in non‐small cell lung adenocarcinoma, which is the most common lung cancer subtype worldwide, resulting in an ideal therapeutic target.4, 5, 6. The gene discussed is EGFR; the disease is hereditary disease.